Network

The public private partnership BIOMAP involves 34 partner institutions from twelve European countries including clinical sites with recognised excellence in clinical care and research as well as industry partners. The BIOMAP consortium brings together partners with strong complementary backgrounds spanning from system biology, molecular disease mapping and single cell analysis to data management and advanced bioinformatics, and with experience in leading international research projects on inflammatory skin diseases.

  • Advisory Board

    Within its patient-centric and impact-oriented approach, BIOMAP brings together key stakeholders groups from multidisciplinary research areas and pharma industry. External Advisory Groups will complement the expertise of the BIOMAP consortium and provide independent advice and recommendations: the Patient Board and the (scientific) Advisory Board. They will provide guidance to obtain a clearer picture on disease subtypes in Atopic Dermatitis and Psoriasis aiming at better drug development which will ultimately lead to improved treatment opportunities.

    The BIOMAP consortium is delighted to have its expertise complemented by the BIOMAP Advisory Board. Members of the Advisory Board comprise renowned scientists in the fields of atopic dermatitis (AD) and Psoriasis (Pso). They will advise the BIOMAP consortium on scientific as well as ethical issues to facilitate strategic decisions and give targeted feedback on the scientific progress of the project and therefore maximize benefits of the project.

    Members

    • International Psoriasis Council
      Francesca Capon, PhD
    • Harmonising Outcome Measures for Eczema (HOME)
      Joanne Chalmers, PhD
    • International Eczema Council
      Dirk Jan Hijnen, PhD
    • Swedish Law and Informatics Research Institute
      Prof. Cecilia M. Sjöberg
  • Patient Board

    The Patient Board has been consulted from the beginning of BIOMAP. The representatives of the Patient Board will give voice to the desires and needs of people with atopic dermatitis (AD) and Psoriasis (Pso) patients. This board consisting of 6 AD and Pso focused patient organisations and will be working within and across Work Packages serving as an advisory resource to BIOMAP.

    The Patient Board will

    • ensure that BIOMAP operates with a patient-centric approach and delivers specific outcomes with the potential to improve the lives of people with AD and Pso;
    • support the communication of BIOMAP results to the wider public;
    • provide advice to the BIOMAP consortium to ensure that the patient perspective is included in the work conducted in BIOMAP
    • provide advice on the design of clinical research activities in BIOMAP.

    Members

    • Eczema Outreach Support (EOS)
      Suzi Holland
    • Dutch Association for People with Atopic Dermatitis (VMCE)
      Bernd Arents
    • Psoriasis Association
      Helen McAteer
    • National Eczema Society
      Andrew Proctor
    • Irish Skin Foundation
      David McMahon and Michelle Greenwood
    • European Psoriasis Association (EUROPSO)
      Lars F. Werner

Meet the Partners

Robert Häsler

Christian Albrechts University of Kiel

meet Robert Häsler ...

Elke Rodríguez

Christian Albrechts University of Kiel

meet Elke Rodríguez ...

Nora B. Hangel

Technical University Munich

meet Nora B. Hangel ...

Matthias Hübenthal

Christian Albrechts University of Kiel

meet Matthias Hübenthal ...

Inês Barbosa

King’s College London

meet Inês Barbosa ...

Vittorio Fortino

University of Eastern Finland (UEF)

meet Vittorio Fortino ...

Antonio Federico

Tampere University

meet Antonio Federico ...

Nick Dand

King’s College London

meet Nick Dand ...